More Information on 'Centogene AG'

Centogene AG is a worldwide leader in genetic diagnostic testing for rare hereditary diseases. The company offers a broad test portfolio covering over 2800 genes, as well as biochemical tests, biomarker analysis, and whole exome and genome sequencing. With a mission to support medical professionals in diagnosing and treating rare diseases, Centogene AG provides high-quality, knowledge-based genetic testing and biomarker development. The company's CentoMD database integrates genetic and clinical information, enabling the highest quality testing and development of new treatments.

About Centogene AG
Centogene is a worldwide leader in the field of genetic diagnostic testing for rare hereditary diseases, with a broad test portfolio covering over 2800 genes, biochemical tests, biomarker and clinical whole exome sequencing and whole genome sequencing. Centogene’s mission is to support medical professionals with in-depth medical expertise to diagnose early and safe the reason for the patients’ burden. Analyzing samples from all over the world allows Centogene to constantly expand its unique portfolio resulting in the largest systematic documentation of the genetic results, named CentoMD®. This mutation database integrates genetic and clinical information, enabling the highest quality, knowledge-based genetic testing and biomarker development. In addition to offering diagnostic services for individual patients, Centogene is a pivotal partner to some of the most respected names in the industry.